Harshit Singh

464 total citations
37 papers, 298 citations indexed

About

Harshit Singh is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Harshit Singh has authored 37 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Harshit Singh's work include Renal Diseases and Glomerulopathies (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Harshit Singh is often cited by papers focused on Renal Diseases and Glomerulopathies (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Harshit Singh collaborates with scholars based in India, United States and United Kingdom. Harshit Singh's co-authors include Vikas Agarwal, Saurabh Chaturvedi, Narayan Prasad, Durga Prasanna Misra, Swasti Tiwari, UC Ghoshal, Mohit Kumar, Rajendra Chaudhary, Raj Kumar Sharma and Ajay Singh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Pharmacology.

In The Last Decade

Harshit Singh

34 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harshit Singh India 10 73 64 58 53 46 37 298
Amir Shabaka Spain 10 76 1.0× 35 0.5× 50 0.9× 42 0.8× 215 4.7× 37 418
Edward Bourry France 10 74 1.0× 36 0.6× 48 0.8× 85 1.6× 129 2.8× 16 359
Ismet Aydogdu Türkiye 11 46 0.6× 45 0.7× 40 0.7× 74 1.4× 19 0.4× 27 370
Hongyan Li China 11 35 0.5× 63 1.0× 35 0.6× 24 0.5× 19 0.4× 38 372
Anna Reznichenko Sweden 10 160 2.2× 46 0.7× 67 1.2× 111 2.1× 97 2.1× 18 445
Zbigniew Hruby Poland 9 62 0.8× 38 0.6× 50 0.9× 56 1.1× 112 2.4× 32 282
M. Motta Italy 11 73 1.0× 56 0.9× 77 1.3× 47 0.9× 105 2.3× 17 377
Feliciano Chanana Paquissi Angola 7 42 0.6× 121 1.9× 55 0.9× 80 1.5× 17 0.4× 9 299
Tomoko Hagiwara Japan 12 109 1.5× 49 0.8× 116 2.0× 38 0.7× 15 0.3× 27 378
Ying‐Ming Chiu Taiwan 11 38 0.5× 98 1.5× 45 0.8× 63 1.2× 26 0.6× 28 363

Countries citing papers authored by Harshit Singh

Since Specialization
Citations

This map shows the geographic impact of Harshit Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harshit Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harshit Singh more than expected).

Fields of papers citing papers by Harshit Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harshit Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harshit Singh. The network helps show where Harshit Singh may publish in the future.

Co-authorship network of co-authors of Harshit Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Harshit Singh. A scholar is included among the top collaborators of Harshit Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harshit Singh. Harshit Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prasad, Narayan, et al.. (2025). Peritoneal Dialysis -Associated Fibrosis: Emerging Mechanisms and Therapeutic Opportunities. Frontiers in Pharmacology. 16. 1635624–1635624.
2.
Singh, Harshit, Miriana Hijaz, Radhika Gogoi, et al.. (2024). Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors. Journal of Ovarian Research. 17(1). 226–226. 8 indexed citations
3.
Chaturvedi, Saurabh, et al.. (2024). Unravelling the role of Sildenafil and SB204741 in suppressing fibrotic potential of peritoneal fibroblasts obtained from PD patients. Frontiers in Pharmacology. 14. 1279330–1279330. 3 indexed citations
4.
Mehta, Pankti, Harshit Singh, Alok Nath, et al.. (2023). Peripheral T helper subset profiling in idiopathic inflammatory myositis: Proof of concept. Reumatología Clínica (English Edition). 19(3). 143–149.
5.
Singh, Harshit, et al.. (2023). Tonsillitis and Sinusitis: A Narrative Review of Pathogenesis, Diagnosis, and Management. Cureus. 15(10). e47192–e47192. 1 indexed citations
6.
Janic, Branislava, Harshit Singh, Haythem Ali, et al.. (2023). Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model. Cancers. 15(20). 4931–4931. 11 indexed citations
7.
Singh, Harshit, et al.. (2023). Exploring the Relation Between Diabetes and HIV: A Narrative Review. Cureus. 15(8). e43909–e43909. 2 indexed citations
8.
Kumar, Mohit, Avinash Jain, Kritika Singh, et al.. (2023). Clinical metabolomics by NMR revealed serum metabolic signatures for differentiating sarcoidosis from tuberculosis. Metabolomics. 19(11). 92–92. 5 indexed citations
9.
Chaturvedi, Saurabh, Rashi Gupta, Harshit Singh, & Sachin Kumar. (2023). Emerging Landscape of Medical Laboratory Science in India: Promises and Opportunities. 5(4). 113–121. 2 indexed citations
10.
Zahiruddin, Quazi Syed, et al.. (2023). Converging Epidemics: A Narrative Review of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) Coinfection. Cureus. 15(10). e47624–e47624. 9 indexed citations
11.
Singh, Harshit, Laila Poisson, Nivedita Tiwari, et al.. (2023). Intermittent fasting induced ketogenesis inhibits mouse epithelial ovarian cancer by promoting antitumor T cell response. iScience. 26(10). 107839–107839. 13 indexed citations
12.
Pandey, Gaurav, Harshit Singh, Saurabh Chaturvedi, et al.. (2021). Utility of neutrophil CD64 in distinguishing bacterial infection from inflammation in severe alcoholic hepatitis fulfilling SIRS criteria. Scientific Reports. 11(1). 19726–19726. 8 indexed citations
13.
14.
Jain, Avinash, et al.. (2020). Distinct T-cell immunophenotypic signature in a subset of sarcoidosis patients with arthritis. The Journal of the Royal College of Physicians of Edinburgh. 50(3). 226–232. 4 indexed citations
15.
Singh, Harshit, et al.. (2019). Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome. Frontiers in Pharmacology. 10. 558–558. 12 indexed citations
16.
Singh, Harshit, Saurabh Chaturvedi, Mohit Kumar, et al.. (2018). Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis. Clinical Rheumatology. 38(4). 997–1005. 22 indexed citations
17.
Prasad, Narayan, Vikas Agarwal, Raj Kumar Sharma, et al.. (2015). Differential alteration in peripheral T-regulatory and T-effector cells with change in P-glycoprotein expression in Childhood Nephrotic Syndrome: A longitudinal study. Cytokine. 72(2). 190–196. 43 indexed citations
18.
Ghoshal, UC, Harshit Singh, & Swasti Tiwari. (2007). Anti-Saccharomyces cerevisiae antibody is not useful to differentiate between Crohn′s disease and intestinal tuberculosis in India. Journal of Postgraduate Medicine. 53(3). 166–170. 28 indexed citations
19.
Singh, Harshit, et al.. (2003). Platelet indices as quality markers of platelet concentrates during storage. Clinical & Laboratory Haematology. 25(5). 307–310. 20 indexed citations
20.
Singh, Harshit, Surender Kumar Yachha, Rajan Saxena, et al.. (2003). A new dimension of 1H‐NMR spectroscopy in assessment of liver graft dysfunction. NMR in Biomedicine. 16(4). 185–188. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026